Christopher Gibson's most recent trade in Recursion Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 40,000 Class A Common Stock done . Disclosure was reported to the exchange on June 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 05 Jun 2026 | 40,000 | 923,735 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 05 Jun 2026 | 40,000 | 4,263,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 3.62 per share. | 05 Jun 2026 | 40,000 | 883,735 | - | 3.6 | 144,800 | Class A Common Stock |
| Pacific Biosciences of California Inc | Dr. Christopher Gibson, PhD | Director | 03 Jun 2026 | 74,497 | 74,497 | - | - | Stock Option (right to buy) | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 22 May 2026 | 40,000 | 923,735 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 22 May 2026 | 40,000 | 4,303,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 3.08 per share. | 22 May 2026 | 40,000 | 883,735 | - | 3.1 | 123,200 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.04 per share. | 15 May 2026 | 22,821 | 883,735 | - | 3.0 | 69,376 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 07 May 2026 | 60,000 | 966,556 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 07 May 2026 | 60,000 | 4,343,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 3.37 per share. | 07 May 2026 | 40,000 | 926,556 | - | 3.4 | 134,800 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 May 2026 | 20,000 | 906,556 | - | 0 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 22 Apr 2026 | 40,000 | 946,556 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 22 Apr 2026 | 40,000 | 4,403,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 3.61 per share. | 22 Apr 2026 | 40,000 | 906,556 | - | 3.6 | 144,400 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 22 Apr 2026 | 40,000 | 946,556 | - | 0 | - | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 3.61 per share. | 22 Apr 2026 | 40,000 | 906,556 | - | 3.6 | 144,400 | - |
| Pacific Biosciences of California Inc | Dr. Christopher Gibson, PhD | Director | 08 Apr 2026 | 77,842 | 77,842 | - | - | Stock Option (right to buy) | ||
| Pacific Biosciences of California Inc | Dr. Christopher Gibson, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2026 | 57,473 | 111,386 (0%) | 0% | 0 | Common Stock | |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 07 Apr 2026 | 40,000 | 946,556 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 07 Apr 2026 | 40,000 | 4,443,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 3.10 per share. | 07 Apr 2026 | 40,000 | 906,556 | - | 3.1 | 124,000 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 07 Apr 2026 | 40,000 | 946,556 | - | 0 | - | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 3.10 per share. | 07 Apr 2026 | 40,000 | 906,556 | - | 3.1 | 124,000 | - |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 23 Mar 2026 | 40,000 | 946,556 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 23 Mar 2026 | 40,000 | 4,483,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 3.25 per share. | 23 Mar 2026 | 40,000 | 906,556 | - | 3.3 | 130,000 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 23 Mar 2026 | 40,000 | 946,556 | - | 0 | - | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 3.25 per share. | 23 Mar 2026 | 40,000 | 906,556 | - | 3.3 | 130,000 | - |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Mar 2026 | 20,000 | 906,556 | - | 0 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 09 Mar 2026 | 20,000 | 926,556 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 09 Mar 2026 | 20,000 | 4,523,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 09 Mar 2026 | 20,000 | 926,556 | - | 0 | - | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Mar 2026 | 20,000 | 906,556 | - | 0 | - | |
| Pacific Biosciences of California Inc | Dr. Christopher Gibson, PhD | Director | 03 Mar 2026 | 73,087 | 73,087 | - | - | Stock Option (right to buy) | ||
| Pacific Biosciences of California Inc | Dr. Christopher Gibson, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2026 | 53,913 | 53,913 (0%) | 0% | 0 | Common Stock | |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 3.46 per share. | 17 Feb 2026 | 40,000 | 906,556 | - | 3.5 | 138,400 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 17 Feb 2026 | 40,000 | 946,556 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 17 Feb 2026 | 40,000 | 4,543,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 17 Feb 2026 | 40,000 | 946,556 | - | 0 | - | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 3.46 per share. | 17 Feb 2026 | 40,000 | 906,556 | - | 3.5 | 138,400 | - |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.49 per share. | 17 Feb 2026 | 27,265 | 906,556 | - | 3.5 | 95,155 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.49 per share. | 17 Feb 2026 | 27,265 | 906,556 | - | 3.5 | 95,155 | - |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 04 Feb 2026 | 40,000 | 953,839 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 04 Feb 2026 | 40,000 | 4,583,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 4.12 per share. | 04 Feb 2026 | 40,000 | 913,839 | - | 4.1 | 164,800 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 04 Feb 2026 | 40,000 | 953,839 | - | 0 | - | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 4.12 per share. | 04 Feb 2026 | 40,000 | 913,839 | - | 4.1 | 164,800 | - |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 30,346 | 944,185 | - | 0 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 30,346 | 944,185 | - | 0 | - | |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.56 per share. | 04 Feb 2026 | 10,364 | 933,821 | - | 3.6 | 36,896 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.56 per share. | 04 Feb 2026 | 10,364 | 933,821 | - | 3.6 | 36,896 | - |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 20 Jan 2026 | 40,000 | 953,839 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 20 Jan 2026 | 40,000 | 4,623,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 4.47 per share. | 20 Jan 2026 | 40,000 | 913,839 | - | 4.5 | 178,800 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 20 Jan 2026 | 40,000 | 953,839 | - | 0 | - | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 4.47 per share. | 20 Jan 2026 | 40,000 | 913,839 | - | 4.5 | 178,800 | - |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 05 Jan 2026 | 60,000 | 973,839 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 05 Jan 2026 | 60,000 | 4,663,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | 05 Jan 2026 | 60,000 | 973,839 | - | 0 | - | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 4.25 per share. | 05 Jan 2026 | 40,000 | 933,839 | - | 4.3 | 170,000 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Sale of securities on an exchange or to another person at price $ 4.25 per share. | 05 Jan 2026 | 40,000 | 933,839 | - | 4.3 | 170,000 | - |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2026 | 20,000 | 913,839 | - | 0 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2026 | 20,000 | 913,839 | - | 0 | - | |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 19 Dec 2025 | 40,000 | 953,839 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 19 Dec 2025 | 40,000 | 4,723,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.50 per share. | 19 Dec 2025 | 40,000 | 913,839 | - | 4.5 | 180,000 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 19 Dec 2025 | 40,000 | 953,839 | - | 0 | - | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.50 per share. | 19 Dec 2025 | 40,000 | 913,839 | - | 4.5 | 180,000 | - |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 04 Dec 2025 | 60,000 | 973,839 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 04 Dec 2025 | 60,000 | 4,763,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 04 Dec 2025 | 60,000 | 973,839 | - | 0 | - | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.63 per share. | 04 Dec 2025 | 40,000 | 933,839 | - | 4.6 | 185,200 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.63 per share. | 04 Dec 2025 | 40,000 | 933,839 | - | 4.6 | 185,200 | - |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Dec 2025 | 20,000 | 913,839 | - | 0 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Dec 2025 | 20,000 | 913,839 | - | 0 | - | |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.14 per share. | 17 Nov 2025 | 40,390 | 913,839 | - | 4.1 | 167,215 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.14 per share. | 17 Nov 2025 | 40,390 | 913,839 | - | 4.1 | 167,215 | - |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 17 Nov 2025 | 40,000 | 4,823,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.16 per share. | 17 Nov 2025 | 40,000 | 913,839 | - | 4.2 | 166,400 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 17 Nov 2025 | 40,000 | 953,839 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 17 Nov 2025 | 40,000 | 953,839 | - | 0 | - | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.16 per share. | 17 Nov 2025 | 40,000 | 913,839 | - | 4.2 | 166,400 | - |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 04 Nov 2025 | 60,000 | 4,863,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 04 Nov 2025 | 60,000 | 1,014,229 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 04 Nov 2025 | 60,000 | 1,014,229 | - | 0 | - | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.21 per share. | 04 Nov 2025 | 40,000 | 974,229 | - | 5.2 | 208,400 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.21 per share. | 04 Nov 2025 | 40,000 | 974,229 | - | 5.2 | 208,400 | - |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Nov 2025 | 20,000 | 954,229 | - | 0 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Nov 2025 | 20,000 | 954,229 | - | 0 | - | |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 23 Oct 2025 | 100,000 | 4,923,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.70 per share. | 23 Oct 2025 | 100,000 | 954,229 | - | 5.7 | 570,000 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 23 Oct 2025 | 100,000 | 1,054,229 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 23 Oct 2025 | 100,000 | 1,054,229 | - | 0 | - | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.70 per share. | 23 Oct 2025 | 100,000 | 954,229 | - | 5.7 | 570,000 | - |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 10 Oct 2025 | 120,000 | 1,074,229 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 10 Oct 2025 | 120,000 | 5,133,034 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | 10 Oct 2025 | 120,000 | 1,074,229 | - | 0 | - | ||
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.04 per share. | 10 Oct 2025 | 100,000 | 974,229 | - | 6.0 | 604,000 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.04 per share. | 10 Oct 2025 | 100,000 | 974,229 | - | 6.0 | 604,000 | - |
| Recursion Pharma Inc (Class A) | Dr. Christopher Gibson, PhD | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Oct 2025 | 20,000 | 954,229 | - | 0 | Class A Common Stock |